People's immune systems deteriorate as they age, making cancer therapies that rely on immune cells difficult to implement. In a new study, researchers from the University of Lausanne (UNIL), the Lausanne University Hospital (CHUV), the Geneva University Hospitals (HUG), and the Ecole Polytec
Researchers at Penn Medicine's Abramson Cancer Centre and the University of Pennsylvania's Perelman School of Medicine have found that a straightforward dietary supplement may offer a novel way to enhance CAR T cell performance.
This initiative, organised in coordination between UAE Pro League, Abu Dhabi Stem Cells Centre, and the Department of Health - Abu Dhabi, underscores the power of innovation and collaboration in the pursuit of better health and well-being, celebrating the young boy's successful treatment
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine C